Novel alkyldioxadiketones as HPPD inhibitors for herbicidal and insecticidal applications
Natural product-based triketone mimics designed as 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors. These rationally designed compounds aim to reduce environmental leaching of classical commercial HPPD inhibitors in soil, sediments, and water while delivering herbicidal and insecticidal activity.
Overview
This research presents a novel class of alkyldioxadiketones designed as inhibitors of 4-hydroxyphenylpyruvate dioxygenase (HPPD), an important enzyme target in agricultural crop protection. The compounds are natural product-based triketone mimics rationally designed to provide herbicidal and insecticidal activity while addressing a key environmental limitation of existing commercial HPPD inhibitors: leaching into soil, sediments, and water. By modifying the chemical scaffold, the researchers aim to retain or improve biological efficacy while reducing environmental mobility and persistence.
Technical specifications
Key features:
- Novel alkyldioxadiketone chemical scaffold derived from natural product triketone templates
- Mechanism of action through inhibition of HPPD, a validated enzyme target in herbicide development
- Rational molecular design aimed at reducing soil and water leaching compared to classical HPPD inhibitors
- Dual-activity potential targeting both weed and insect pest management
- Synthesized as a defined set of structural analogs for structure-activity evaluation
Technology readiness level
The compounds are at an early research stage. Synthesis of the initial compound set has been completed, with biological evaluation against HPPD and assessment of herbicidal and insecticidal activity still required. Future work will include additional validation studies to confirm efficacy, environmental leaching behavior, and potential field performance.
About University of Mississippi
A leading public research university in Mississippi, the University of Mississippi spans its main campus in Oxford and an academic medical center in Jackson, combining broad academic strength with a collaborative, service-oriented culture. Industry partners engage through a research and technology park that offers incubator space, shared core facilities, and collaboration suites next to campus. Integration with a major hospital system enables large-scale clinical research, access to clinical data, and translation from lab to care, while proximity to the Memphis logistics hub and regional manufacturing corridors shortens timelines from prototype to pilot. Research is supported by competitive federal funding, including awards from NIH, NSF, and the Department of Defense. A dedicated technology transfer office manages IP and licensing and supports startup formation within the park.
delivered to your inbox.